Your browser doesn't support javascript.
Post COVID and Apheresis - Where are we Standing?
Steenblock, Charlotte; Walther, Romy; Tselmin, Sergey; Jarzebska, Natalia; Voit-Bak, Karin; Toepfner, Nicole; Siepmann, Timo; Passauer, Jens; Hugo, Christian; Wintermann, Gloria; Julius, Ulrich; Barbir, Mahmoud; Khan, Tina Z; Puhan, Milo A; Straube, Richard; Hohenstein, Bernd; Bornstein, Stefan R; Rodionov, Roman N.
  • Steenblock C; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Walther R; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Tselmin S; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Jarzebska N; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Voit-Bak K; University Center for Vascular Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Toepfner N; Zentrum für Apherese- und Hämofiltration am INUS Tagesklinikum, Cham, Germany.
  • Siepmann T; Department of Pediatrics, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Passauer J; Department of Neurology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Hugo C; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Wintermann G; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Julius U; Department of Psychotherapy and Psychosomatic Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Barbir M; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Khan TZ; Department of Cardiology, Harefield Hospital, Harefield, United Kingdom of Great Britain and Northern Ireland.
  • Puhan MA; Department of Cardiology, Harefield Hospital, Harefield, United Kingdom of Great Britain and Northern Ireland.
  • Straube R; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Hohenstein B; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Bornstein SR; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Rodionov RN; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Horm Metab Res ; 54(11): 715-720, 2022 Nov.
Article in English | MEDLINE | ID: covidwho-2096875
ABSTRACT
A continual increase in cases of Long/Post COVID constitutes a medical and socioeconomic challenge to health systems around the globe. While the true extent of this problem cannot yet be fully evaluated, recent data suggest that up to 20% of people with confirmed SARS-CoV-2 suffer from clinically relevant symptoms of Long/Post COVID several weeks to months after the acute phase. The clinical presentation is highly variable with the main symptoms being chronic fatigue, dyspnea, and cognitive symptoms. Extracorporeal apheresis has been suggested to alleviate symptoms of Post/COVID. Thus, numerous patients are currently treated with apheresis. However, at present there is no data from randomized controlled trials available to confirm the efficacy. Therefore, physicians rely on the experience of practitioners and centers performing this treatment. Here, we summarize clinical experience on extracorporeal apheresis in patients with Post/COVID from centers across Germany.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Component Removal / COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Horm Metab Res Year: 2022 Document Type: Article Affiliation country: A-1945-9694

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Component Removal / COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Horm Metab Res Year: 2022 Document Type: Article Affiliation country: A-1945-9694